Fibroblast PIEZO1 Promotes Autoimmune Valvular Carditis 2328060

Abstract Introduction Cardiac valve inflammation accompanies several autoantibody-mediated diseases. Interestingly, this pathology is typically restricted to the higher pressure left side of the heart (mitral and aortic valves), suggesting a link between mechanical stress and inflammation. The K/B.g7 mouse model of autoimmune arthritis and valvular carditis recapitulates key aspects of autoimmune valvular carditis in humans, including attack of the left-sided cardiac valves. We hypothesized that mechanosensing drives this side-specific susceptibility and investigated the role of PIEZO1, a mechanosensitive ion channel, in mediating autoimmune valvular carditis. Methods Using the K/B.g7 mouse model, we conditionally deleted PIEZO1 in endothelial cells (Cdh5-Cre), macrophages (Cx3Cr1-Cre), and fibroblasts (Tcf21-Cre). Cdh5 and Tcf21 Cre-mediated deletion were induced via oral tamoxifen gavage at 4 weeks of age, whereas Cx3cr1 Cre-mediated deletion was constitutive. Hearts were harvested from 8-week-old mice. Valve thickness and pathology were quantified via hematoxylin and eosin (H&E) staining of histological sections. Results Deletion of PIEZO1 in Tcf21+ fibroblasts significantly reduced valve inflammation and thickening (p = 0.0343). In contrast, PIEZO1 deletion in endothelial cells (p = 0.7984) or macrophages (p = 0.9118) did not attenuate pathology. Preliminary experiments show no significant differences in valve adhesion receptor expression, cellular proliferation, or collagen organization following fibroblast-specific loss of PIEZO1. Conclusion These results demonstrate that PIEZO1 expressed by Tcf21+ fibroblasts is a critical contributor to mitral valve inflammation in autoimmune valvular carditis. While specific downstream mechanisms remain to be elucidated, they likely include numerical cell changes, extracellular matrix remodeling, and/or altered intercellular communication. These findings suggest that fibroblast-mediated mechanosensing could underlie the left-sided bias observed in autoimmune valvular carditis. Funding Source 1T32HL166142-01 5T32AI007313-36 5R01HL121093-10 Topic Categories Basic Autoimmunity (BA)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2026-07-28
DOI
https://doi.org/10.1093/jimmun/vkag141.1763
Primary Topic
Erythrocyte Function and Pathophysiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fibroblast PIEZO1 Promotes Autoimmune Valvular Carditis 2328060

Lucas Menéndez, A. B. Peck, Charles Roll, Bryce Binstadt et al.
The Journal of Immunology
Erythrocyte Function and Pathophysiology
article

Fibroblast PIEZO1 Promotes Autoimmune Valvular Carditis 2328060

Lucas Menéndez, A. B. Peck, Charles Roll, Bryce Binstadt, Jennifer Auger, Michelle Tallquist
article en

Abstract

Abstract Introduction Cardiac valve inflammation accompanies several autoantibody-mediated diseases. Interestingly, this pathology is typically restricted to the higher pressure left side of the heart (mitral and aortic valves), suggesting a link between mechanical stress and inflammation. The K/B.g7 mouse model of autoimmune arthritis and valvular carditis recapitulates key aspects of autoimmune valvular carditis in humans, including attack of the left-sided cardiac valves. We hypothesized that mechanosensing drives this side-specific susceptibility and investigated the role of PIEZO1, a mechanosensitive ion channel, in mediating autoimmune valvular carditis. Methods Using the K/B.g7 mouse model, we conditionally deleted PIEZO1 in endothelial cells (Cdh5-Cre), macrophages (Cx3Cr1-Cre), and fibroblasts (Tcf21-Cre). Cdh5 and Tcf21 Cre-mediated deletion were induced via oral tamoxifen gavage at 4 weeks of age, whereas Cx3cr1 Cre-mediated deletion was constitutive. Hearts were harvested from 8-week-old mice. Valve thickness and pathology were quantified via hematoxylin and eosin (H&E) staining of histological sections. Results Deletion of PIEZO1 in Tcf21+ fibroblasts significantly reduced valve inflammation and thickening (p = 0.0343). In contrast, PIEZO1 deletion in endothelial cells (p = 0.7984) or macrophages (p = 0.9118) did not attenuate pathology. Preliminary experiments show no significant differences in valve adhesion receptor expression, cellular proliferation, or collagen organization following fibroblast-specific loss of PIEZO1. Conclusion These results demonstrate that PIEZO1 expressed by Tcf21+ fibroblasts is a critical contributor to mitral valve inflammation in autoimmune valvular carditis. While specific downstream mechanisms remain to be elucidated, they likely include numerical cell changes, extracellular matrix remodeling, and/or altered intercellular communication. These findings suggest that fibroblast-mediated mechanosensing could underlie the left-sided bias observed in autoimmune valvular carditis. Funding Source 1T32HL166142-01 5T32AI007313-36 5R01HL121093-10 Topic Categories Basic Autoimmunity (BA)

The Journal of ImmunologyVol. 215(Supplement_1)
University of Hawaiʻi at Mānoa (US), University of Minnesota (US), Florida International University (US), University of Minnesota System (US), Twin Cities Orthopedics (US)
Good health and well-being
Openalex Percentile: Top 9%
Erythrocyte Function and Pathophysiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.